×

Sign In

Search
Home

Sangamo to reclaim hemophilia A therapy rights post Pfizer termination

By Thomson Reuters Dec 30, 2024 | 3:34 PM

(Reuters) – Sangamo Therapeutics said on Monday it would regain full rights to its hemophilia A gene therapy after co-development partner Pfizer terminated the agreement.

(Reporting by Puyaan Singh in Bengaluru; Editing by Mohammed Safi Shamsi)

BUSH's GAVIN ROSSDALE was on "Border Crossings" chatting about the NEW album comin' in 2025....

ALICE COOPER has a non-alcoholic cocktail - Sex, Drugs, Rock & Dry - available for Dry January....

Giannis Antetokounmpo, Nikola Jokic lead All-Star fan vote

Ukraine's Zelenskiy: Trump can be 'decisive' in helping stop Russia's Putin

Steelworkers union criticizes Nippon Steel's proposal for lack of long-term commitment

Fire transfer D Tobias Salquist to Danish club

Privacy Policy
Terms Of Service

Midwest Communications, Inc.

Copyright © 2025. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.